Verge Chief Medical Officer, Diego Cadavid, to present at PBSS

Our Chief Medical Officer, Diego Cadavid, will be presenting at the Pharmaceutical and Bioscience Society International (PBSS) Virtual Conference on Emerging Biology and Therapeutics. He'll be sharing insights on Verge’s innovative proof-of-concept study of VRG50468, a PIKfyve inhibitor, for the treatment of Amyotrophic Lateral Sclerosis (ALS).